In March 2025, the company declared new strategies for the direct-to-shopper providing of its Wegovy weight loss drug. The company founded a whole new pharmacy, known as NovoCare, which might cost consumers $499 every month for use of the drug, lower than 50 % the cost of the drug by means of other pharmaceutical distribution networks.[53]The next